| 000 | 01044 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513234053.0 | ||
| 264 | 0 | _c20010329 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(05)71277-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOudesluys-Murphy, A M | |
| 245 | 0 | 0 |
_aGalactorrhoea, hyperprolactinaemia, and protease inhibitors. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 2001 |
||
| 300 |
_a474-5 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGalactorrhea _xchemically induced |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactation _xdrug effects |
| 650 | 0 | 4 |
_aMetoclopramide _xadverse effects |
| 773 | 0 |
_tLancet (London, England) _gvol. 357 _gno. 9254 _gp. 474-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(05)71277-0 _zAvailable from publisher's website |
| 999 |
_c11209207 _d11209207 |
||